Chinese Guidelines on the Diagnosis and Treatment of Melanoma (2015 Edition).
Ontology highlight
ABSTRACT:
SUBMITTER: Guo J
PROVIDER: S-EPMC4690993 | biostudies-literature | 2015 Dec
REPOSITORIES: biostudies-literature
Publications
Chinese Guidelines on the Diagnosis and Treatment of Melanoma (2015 Edition).
Guo Jun J Qin Shukui S Liang Jun J Lin Tongyu T Si Lu L Chen Xiaohong X Chi Zhihong Z Cui Chuanliang C Du Nan N Fan Yun Y Gu Kangsheng K Li Fang F Li Junling J Li Yongheng Y Liang Houjie H Liu Jiwei J Lu Man M Lu Aiping A Nan Kejun K Niu Xiaohui X Pan Hongming H Ren Guoxin G Ren Xiubao X Shu Yongqian Y Song Xin X Tao Min M Wang Baocheng B Wei Wenbin W Wu Di D Wu Lingying L Wu Aiwen A Xu Xiaolin X Zhang Junyi J Zhang Xiaoshi X Zhang Yiping Y Zhu Huiyan H
Annals of translational medicine 20151201 21
Similar Datasets
Project description: Not available
| S-EPMC11815422 | biostudies-literature
Project description:Osteoarthritis (OA) is a degenerative disease of middle-aged and elderly people, contributed a higher burden of disease in China and the world. In 2017, under the support of the Rheumatology and Immunology Expert Committee of the Cross-Strait Medical and Health Exchange Association. The objective was to develop an evidence-based diagnosis and treatment guideline for OA in China based on emerging new evidence. The guideline was registered at International Practice Guidelines Registry Platform (IPGRP-2018CN028). The grading of recommendations assessment, development and evaluation (GRADE) approach was used to rate the quality of evidence and the strength of recommendations, and the RIGHT (Reporting Items for Practice Guidelines in Healthcare) checklist was followed to report the guideline. The guideline provides recommendations for the OA diagnosis, disease risks monitoring and evaluate, treatment purpose and physical, medical and surgical interventions. This guideline is intended to serve as a tool for Chinese clinicians for the best decisions-making on diagnosis and treatment of OA.
| S-EPMC7607097 | biostudies-literature
Project description:Renal cancer is one of the most common malignancies of the urinary system, and the number of deaths continues to increase. The standardized management of the diagnosis and treatment of renal cancer is challenging due to the great differences in the diagnosis and treatment of renal cancer in different regions. The Renal Cancer Expert Committee of the National Cancer Quality Control Center (NCQCC) identified a lack of authoritative quality control standards as an opportunity to utilize its multidisciplinary membership to improve the standardized diagnosis and treatment of renal cancer. The Renal Cancer Expert Committee of the NCQCC aims to promote quality control and national standardization, uniformity, and normalization of renal cancer diagnosis and treatment, which ultimately improved the survival rate and quality of life of renal cancer patients. A panel of experts with renal cancer surgery, renal cancer medicine, medical imaging, pathology and radiotherapy were drawn together and determined the quality control standards for the standardized diagnosis and treatment of renal cancer. The Indices includes 20 items that cover all key areas in the diagnosis and treatment of renal cancer, such as standard diagnosis, surgery treatment, systemic treatment, and prognostic evaluation.
| S-EPMC11256713 | biostudies-literature
Project description:BackgroundAs an auxiliary tool, intraoperative neuromonitoring (IONM) has played an active role in the protection of nerve function in thyroid and parathyroid surgeries. This study aimed to help clinicians understand, standardize and reasonably apply IONM techniques in laryngeal nerves function protecting.MethodsHundreds of Chinese experts in the field of IONM participated in this work. All efforts have been made to ensure that these new guidelines are practical, systematic, and based on well-recognized cutting-edge evidence. Using the three previous guidelines as well as new preclinical and clinical evidence from China and other countries, the expert panel summarized the current accepted or near-accepted opinions as the recommendations. In addition, the recommendation grades and evidence levels are presented in accordance with the Grading of Recommendations Assessment, Development and Evaluation (GRADE). The first draft was completed by the writing team and then revised after several rounds of discussions via email or meetings.ResultsThe finalized version of this guideline includes 42 recommendations, which may inform and guide our peers in their clinical practice, including all types of open, endoscopic, and robotic thyroid and parathyroid surgeries.ConclusionsThis edition is currently the most comprehensive, and clinically significant guide for IONM of thyroid and parathyroid surgery in China.
| S-EPMC10493630 | biostudies-literature
Project description:Allergic rhinitis (AR) is a global health problem that causes major illnesses and disabilities worldwide. Epidemiologic studies have demonstrated that the prevalence of AR has increased progressively over the last few decades in more developed countries and currently affects up to 40% of the population worldwide. Likewise, a rising trend of AR has also been observed over the last 2-3 decades in developing countries including China, with the prevalence of AR varying widely in these countries. A survey of self-reported AR over a 6-year period in the general Chinese adult population reported that the standardized prevalence of adult AR increased from 11.1% in 2005 to 17.6% in 2011. An increasing number of Journal Articles and imporclinical trials on the epidemiology, pathophysiologic mechanisms, diagnosis, management and comorbidities of AR in Chinese subjects have been published in international peer-reviewed journals over the past 2 decades, and substantially added to our understanding of this disease as a global problem. Although guidelines for the diagnosis and treatment of AR in Chinese subjects have also been published, they have not been translated into English and therefore not generally accessible for reference to non-Chinese speaking international medical communities. Moreover, methods for the diagnosis and treatment of AR in China have not been standardized entirely and some patients are still treated according to regional preferences. Thus, the present guidelines have been developed by the Chinese Society of Allergy to be accessible to both national and international medical communities involved in the management of AR patients. These guidelines have been prepared in line with existing international guidelines to provide evidence-based recommendations for the diagnosis and management of AR in China.
| S-EPMC6021586 | biostudies-literature
Project description: Not available
| S-EPMC6433580 | biostudies-literature
Project description:The Committee for Clinical Guidelines for the Diagnosis and Treatment of HIV/AIDS of the Korean Society for AIDS was founded in 2010. The first edition of the Korean guidelines was published in 2011, and revised in 2013. The recommendations in the guideline contain important information for physicians working with HIV/AIDS in the clinical field. However, due to the rapid discovery of new data in the field of HIV and the evolution of the clinical environment in Korea, it has become necessary to revise the guideline again. This guideline aims to provide up-to-date comprehensive information regarding the diagnosis and management of HIV/AIDS in Korea. This guideline deals with issues regarding the initial assessment of newly diagnosed patients, timing of antiretroviral treatment (ART) initiation, preferred ART regimens in treatment-naïve as well as treatment-experienced patients and special populations such as HBV/HCV co-infected patients, or pregnant women. A brief summary of the revised guidelines and key changes to the original version of the guidelines are summarized below.
| S-EPMC4607777 | biostudies-literature
Project description: Not available
| S-EPMC8116006 | biostudies-literature
Project description:Pancreatic cancer is one of the leading causes of cancer-related mortality in both developed and developing countries. The incidence of pancreatic cancer in China accounts for about a quater of the global incidence, and the epidemiological characteristics and therapeutic strategies differ due to social, economic, cultural, environmental, and public health factors. Non-domestic guidelines do not reflect the clinicopathologic characteristics and treatment patterns of Chinese patients. Thus, in 2018, the Chinese Society of Clinical Oncology (CSCO) organized a panel of senior experts from all sub-specialties within the field of pancreatic oncology to compile the Chinese guidelines for the diagnosis and treatment of pancreatic cancer. The guidelines were made based on both the Western and Eastern clinical evidence and updated every one or two years. The experts made consensus judgments and classified evidence-based recommendations into various grades according to the regional differences, the accessibility of diagnostic and treatment resources, and health economic indexes in China. Here we present the latest version of the guidelines, which covers the diagnosis, treatment, and follow-up of pancreatic cancer. The guidelines might standardize the diagnosis and treatment of pancreatic cancer in China and will encourage oncologists to design and conduct more clinical trials about pancreatic cancer.
| S-EPMC11256594 | biostudies-literature
Project description:BackgroundA higher compliance with clinical guidelines helps improve treatment outcomes. But the clinical practice of otolaryngologists is not always consistent with guidelines.ObjectiveTo describe otolaryngologists' compliance with guidelines about allergic rhinitis (AR) management and identify factors responsible for the discordance between clinical practice and guideline recommendations in China.MethodsA cross-sectional nationwide survey was designed and conducted via an online platform. Recruitment was done by emailing otolaryngologists registered in the Chinese Society of Otorhinolaryngology-Head and Neck Surgery or by inviting otolaryngologists to scan a Quick Respond (QR) code that linked to the questionnaire at various academic meetings.ResultsA total of 2142 otolaryngologists were eligible and completed the survey. Of them, 64.7% had over 10 years work experience and 97.4% had a bachelor's degree or higher. About 18.3% of the participants strictly copied the guideline in clinical practice, while 73.7% used the guideline that had been adjusted according to their clinical experience. Otolaryngologists were most concerned about the efficacy, safety, and minimum age of AR medications, and least concerned about patient preferences. Regarding the use of intranasal steroids (INS), leukotriene receptor antagonists (LTRA), and H1-antihistamines, 86.8%, 55.7% and 51.2% of otolaryngologists complied with the guideline recommendations, respectively. Educational background was a factor affecting the compliance with guidelines and acceptance of INS.ConclusionA vast majority of Chinese otolaryngologists complied with the current Chinese AR guidelines. A difference still existed between the otolaryngologists' real-world and guideline-recommended management. The otolaryngologists should pay more attention to patient preferences. A higher education could improve otolaryngologists' adherence to the guidelines.
| S-EPMC8192728 | biostudies-literature